Royce & Associates
SGHT icon

Royce & Associates’s Sight Sciences SGHT Stock Holding History

Royce & Associates’s Portfolio SGHT Stock Details SGHT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.68M Buy
+179,043
New +$1.27M 0.02% 641

Other funds holding SGHT

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Squarepoint
Squarepoint New York $90.8B AUM 26.98% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Parallel Advisors
Parallel Advisors San Francisco, California $7.42B AUM 27.68% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Foster Victor Wealth Advisors
Foster Victor Wealth Advisors Greenville, South Carolina $2.02B AUM 20.94% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 33.83% 1-Year Est. Return
RS
R Squared Central, Hong Kong $188M AUM 18.2% 1-Year Est. Return

Royce & Associates's SGHT Position: Q3 2026 in Review

Royce & Associates opened a new position in Sight Sciences (SGHT) in Q3 2026: 179,043 shares worth $1.68M. The stake represents 0.02% of the portfolio and ranks #641 among its holdings.

40 funds tracked by Wall St. Rank hold SGHT as of Q3 2026.

  • Royce & Associates held 179,043 shares of Sight Sciences worth $1.68M as of Q3 2026.
  • Sight Sciences was a new Royce & Associates position in Q3 2026.
  • Sight Sciences made up 0.02% of Royce & Associates's portfolio in Q3 2026, its #641 holding.
  • 40 funds tracked by Wall St. Rank held Sight Sciences as of Q3 2026.

Based on Royce & Associates's 13F filing for Q3 2026, filed 9 Nov 2026.